<DOC>
	<DOCNO>NCT01602835</DOCNO>
	<brief_summary>This prospective cross-sectional , observational , single-center study Alport patient , single , first morning void urine collection acquire used validate assay urine biomarkers reflect change glomerular protein filtration barrier function . The purpose study identify biomarkers indicative change glomerular filtration function occur course proteinuric renal disease Alport nephropathy .</brief_summary>
	<brief_title>Human Urine Sample Collection Alport Nephropathy Biomarker Studies</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Nephritis , Hereditary</mesh_term>
	<criteria>Inclusion criterion : Alport syndrome diagnosis ( clinical and/or histopathologic and/or genetic diagnosis , per subject 's physician and/or genotyping ) Physically able provide single firstmorning urine sample least 30 mL Exclusion criterion : Diagnosis chronic kidney disease Receiving chronic phosphatelowering therapy erythropoietin therapy Ongoing chronic hemodialysis therapy and/or renal transplant recipient Nephroticrange proteinuria : spot urine proteintocreatinine ratio â‰¥ 3 least 2 last 3 clinical assessment Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Alport syndrome</keyword>
	<keyword>proteinuria</keyword>
	<keyword>glomerular disease</keyword>
	<keyword>hereditary nephropathy</keyword>
	<keyword>nephropathy</keyword>
</DOC>